Many consumers turned to these less-expensive compounded versions of the weight-loss and diabetes drugs because they said they could not afford the brand medications
Citations Klausen MK et al, "Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial." The Lancet, May 2, 2026
Wegovy and Mounjaro are there to reduce the risk associated with medically assisted weight loss, and are both approved weight management injections available in the UK through iQ Doctor, with proven effectiveness and medical supervision
If you are using a pen device (Ozempic or Wegovy), do not try to estimate half-doses by partially pressing the injection button
No differences in brain activations were found after longer periods, for example after 6 weeks of tirzepatide [67] or 12 weeks of liraglutide treatment [68]